TOMSK, RUSSIA / RankWire.AI / – Russian scientists have conducted tests on a bioactive coating aimed at enhancing the interaction between titanium orthopedic implants and bone tissue. The innovative material incorporates calcium phosphate derived from hydroxyapatite and contains nitrogen compounds linked with nitric oxide production. Laboratory experiments demonstrated a notable increase in the survival rate of human mesenchymal stem cells on coated surfaces compared to uncoated titanium. The scientists examined the coating’s structural, chemical, mechanical, and biological aspects. Their peer-reviewed results appeared in Applied Surface Science in 2026.
At Tomsk Polytechnic University, researchers developed the experimental coatings using reactive magnetron sputtering of a hydroxyapatite target within a vacuum chamber. They manipulated the nitrogen and argon gas ratios during deposition to observe how each mixture influenced the surface characteristics. The study tested five different conditions, from pure nitrogen to pure argon, measuring parameters such as coating thickness, surface morphology, hardness, wettability, and chemical makeup. Additionally, laboratory tests assessed how living human cells responded to the modified titanium surfaces.
The results indicated that the argon concentration impacted several physical properties of the coatings. Surfaces created with pure argon were denser and exhibited greater hardness than those formed in pure nitrogen. An increase in argon proportion also led to thicker coatings. Chemical analysis detected nitrogen-carbon and nitrogen-oxygen bonds on the modified surfaces. The team then compared human mesenchymal stem cells grown on coated titanium with those on uncoated samples. The biological assessments focused on cell viability and markers related to bone cell development.
Cell Survival Benefits Observed in Coating Tests
According to the study, cell experiments showed significantly improved survival rates on coated surfaces relative to uncoated titanium. After seven days, coatings with higher nitrogen levels also suppressed activity in certain genes associated with early stages of bone-cell differentiation. Nevertheless, the cells maintained their potential for bone formation despite changes in initial gene activity. These tests were carried out under controlled laboratory conditions using human mesenchymal stem cells. The research did not include clinical trials or evaluate the performance of implanted devices in patients.
The biomedical evaluation was conducted by experts from Immanuel Kant Baltic Federal University and Siberian State Medical University, with additional contributions from Saint Petersburg State University. The project was funded through Russia’s national science program. The researchers aimed to identify gas mixtures capable of producing coatings with a combination of desirable physical, chemical, and biological properties. Hydroxyapatite’s calcium phosphate composition makes it suitable for implant coatings, as it resembles the mineral component found naturally in human bone.
Research Still in the Laboratory Phase
The research team has outlined plans for further testing beyond the initial seven-day cell viability assessment. They intend to monitor stem cell responses over periods of 10 to 28 days and evaluate the rate at which the coatings dissolve. Additionally, they aim to measure nitric oxide release into surrounding tissues in living organisms. These future investigations were not part of the current published laboratory results. Presently, the focus remains on coated titanium substrates, their material properties, and in vitro cellular responses, rather than clinical outcomes in orthopedic patients.
The study provides detailed laboratory data on how variations in nitrogen and argon ratios influence calcium phosphate coatings on titanium surfaces. It documents differences in coating thickness, density, hardness, chemical bonding, and cell response across the tested gas mixtures. The results also confirm that coated samples support higher survival rates of stem cells compared to bare titanium under laboratory conditions. However, the research remains at the preclinical stage, and the experiments do not establish safety or effectiveness for human use. Additional biological testing will be necessary to evaluate properties not addressed in the current study.